Researchers Tuba Güllü Koca
Tuba Güllü Koca profile image
Tuba Güllü Koca Professional ULUDAĞ ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, İÇ HASTALIKLARI ANABİLİM DALI, HEMATOLOJİ BİLİM DALI
Publication 7 Review 0
7 Publication
0 Review

Research Fields

Haematology

Institution

ULUDAĞ ÜNİVERSİTESİ, TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, İÇ HASTALIKLARI ANABİLİM DALI, HEMATOLOJİ BİLİM DALI

Publications

Potential prognostic parameters and real-world data in patients with primary central nervous system lymphoma: a new brick on the old ones
Authors: Tuba Ersal , Vildan Ozkocaman , İbrahim Ethem Pınar , Cumali Yalçın , Bedrettin Orhan , Ömer Candar , Sinem Çubukçu , Tuba Güllü Koca , Rıdvan Ali , Fahir Özkalemkaş
Published: 2023 , The European Research Journal
DOI: 10.18621/eurj.1267903
FAVORITE 0 TOTAL DOWNLOAD COUNT 204

0

204

Combination Experience of Ixazomib, Lenalidomide, Dexamethasone in Relapsed Refractory Multiple Myeloma: Real-Life Data
Authors: Tuba Ersal , Vildan Ozkocaman , Cumali Yalçın , Bedrettin Orhan , Ömer Candar , Sinem Çubukçu , Tuba Güllü Koca , Fazıl Cagrı Hunutlu , Şeyma Yavuz , İbrahim Ethem Pınar , Rıdvan Ali , Fahir Özkalemkaş
Published: 2023 , Journal of Uludağ University Medical Faculty
DOI: 10.32708/uutfd.1249696
FAVORITE 0 TOTAL DOWNLOAD COUNT 373

0

373

Use of dapsone in chronic/refractory immune thrombocytopenic patients: A single center experience
Authors: Ömer Candar , Vildan Ozkocaman , Tuba Ersal , Tuğçe Zor Turna , İbrahim Ethem Pınar , Cumali Yalçın , Bedrettin Orhan , Sinem Çubukçu , Tuba Güllü Koca , Rıdvan Ali , Fahir Özkalemkaş
Published: 2023 , Turkish Journal of Internal Medicine
DOI: 10.46310/tjim.1211506
FAVORITE 0 TOTAL DOWNLOAD COUNT 334

0

334

Subcutaneous and Intravenous Cladribine Treatment of Hairy Cell Leukemia Patients: Do We Still Need Intravenous Cladribine?
Authors: Tuba Ersal , Fahir Özkalemkaş , Vildan Ozkocaman , İbrahim Ethem Pınar , Cumali Yalçın , Bedrettin Orhan , Ömer Candar , Sinem Çubukçu , Tuba Güllü Koca , Rıdvan Ali
Published: 2023 , Turkish Journal of Internal Medicine
DOI: 10.46310/tjim.1239905
FAVORITE 0 TOTAL DOWNLOAD COUNT 267

0

267

Use of Bosutinib in Patients With Chronic Phase Cml: A Single Center Experience
Authors: Tuba Güllü Koca , İbrahim Ethem Pınar , Tuba Ersal , Cumali Yalçın , Bedrettin Orhan , Ömer Candar , Sinem Çubukçu , Fazıl Cagrı Hunutlu , Rıdvan Ali , Vildan Ozkocaman , Fahir Özkalemkaş
Published: 2022 , Journal of Uludağ University Medical Faculty
DOI: 10.32708/uutfd.1165092
FAVORITE 0 TOTAL DOWNLOAD COUNT 498

0

498

Langerhans Cell Histiocytosis, a Rare Disease in Adults: 22 Years of Single Center Experience
Authors: Tuba Ersal , Vildan Ozkocaman , Cumali Yalçın , Bedrettin Orhan , Ömer Candar , Sinem Çubukçu , Tuba Güllü Koca , Rıdvan Ali , Fahir Özkalemkaş
Published: 2022 , Journal of Uludağ University Medical Faculty
DOI: 10.32708/uutfd.1165140
FAVORITE 0 TOTAL DOWNLOAD COUNT 2430

0

2430

Comparison of Clinical Data and Treatment Responses of Patients with Essential Thrombocythemia Using Anagrelide by JAK2 Gene Mutation Status
Authors: Tuba Güllü Koca , Fahir Özkalemkaş , Vildan Ozkocaman , Tuba Ersal , Şeyma Esenbuğa
Published: 2022 , Turkish Journal of Internal Medicine
DOI: 10.46310/tjim.1080749
FAVORITE 0 TOTAL DOWNLOAD COUNT 256

0

256

Articles published in
Journal of Uludağ University Medical Faculty
Journal of Uludağ University Medical Faculty
The European Research Journal
The European Research Journal
Turkish Journal of Internal Medicine
Turkish Journal of Internal Medicine
User doesn't have any peer review duties on DergiPark.
There are no Crossref cited.
Popular Publications: It is determined automatically by the researchers doing research in DergiPark according to the statistics of being added to the favorites. CrossRef Cited: The citations shown in DergiPark are drawn from CrossRef. For this, the cited and cited articles must be registered in CrossRef (DOI number). ^: Citation numbers are reflected in the system by DergiPark at certain periods.
Interactive Guide Tool
If you want to see the panel introduction, you can click Start Tour.